UCLA Jonsson Center PI Leads Study to Suppress Male Hormone in Attempt to Reduce COVID-19 Severity

University of Los Angeles, California (UCLA) researchers are pursuing COVID-19 via a commonly used method to treat men with prostate cancer in an effort to help drive improved clinical outcomes for individuals afflicted with SARS-CoV-2, the virus behind COVID-19....

U.S Department of Veterans Affairs Launches Clinical Trial Investigating Degarelix as COVID-19 Treatment for Hospitalized Males

The U.S. Department of Veterans Affairs launched a clinical trial to investigate the efficacy of an U.S. Food and Drug Administration (FDA)—approved prostate cancer drug for male veterans infected with SARS-CoV-2, the virus behind the COVID-19 pandemic. Investigators...

Pin It on Pinterest